AMBQ
VENTE TOTALE: 184 000 titres (~10 715 871,23 $ US)
- Insiders
- Esaka Fumihide, Hanson Scott McLean
- Total bought
- —
- Total sold
- $10,715,871
- Last activity
- 2026-09-02
- Last synced
-
2026-09-08 09:54:45
Insider holdings as a share of total assets aren't available for this company.
Price (1 year)
Live chart from TradingView - pulls its own market data, independent of this site's database. Symbol resolution is best-effort (defaults to NASDAQ) since we don't store the exchange prefix.
Market snapshot
Signal
Neutral signal Scored 2026-09-04
AMBQ presents a compelling earnings catalyst with an 89.7% revenue surge driven by edge AI demand and a 41% analyst upside projection, but this is significantly tempered by severe underlying financial distress —…
The first sentence of the analysis written for AMBQ on 2026-09-04 - a real excerpt, not a sample. The rest of it, the 0-100 score and the rating it produced are part of Plus. See plans.
Financial ratios
| Metric | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Gross Profit Margin | 35.4% | 31.9% | 29.7% | 33.8% | 42.3% | |
| Ebit Margin | -50.2% | -52.1% | -76.8% | -26.9% | -39.7% | |
| Ebitda Margin | -40.3% | -43.9% | -65.0% | -24.0% | -35.9% | |
| Operating Profit Margin | -56.7% | -53.4% | -78.3% | -27.6% | -39.7% | |
| Pretax Profit Margin | -50.2% | -52.1% | -76.8% | -27.8% | -49.4% | |
| Continuous Operations Profit Margin | -50.3% | -52.1% | -76.8% | -27.8% | -49.5% | |
| Net Profit Margin | -50.3% | -52.1% | -76.8% | -27.8% | -49.5% | |
| Bottom Line Profit Margin | -50.3% | -55.7% | -79.8% | -27.8% | -49.5% | |
| Current Ratio | 8.725 | 7.559 | 4.944 | 6.678 | 15.587 | |
| Quick Ratio | 7.841 | 6.284 | 3.281 | 4.402 | 14.365 | |
| Solvency Ratio | -1.316 | -1.803 | -3.204 | -1.410 | -3.156 | |
| Cash Ratio | 7.314 | 5.182 | 2.115 | 1.752 | 10.698 | |
| Price To Earnings Ratio | -6.236 | -12.310 | -7.706 | -385.300 | -20.827 | |
| Price To Earnings Growth Ratio | -0.136 | 0.329 | 0.000 | 4.073 | 0.000 | |
| Forward Price To Earnings Growth Ratio | -0.136 | 0.329 | 0.000 | 4.073 | 0.000 | |
| Price To Earnings Diluted Ratio | -6.236 | -12.310 | -7.706 | -385.300 | -20.827 | |
| Price To Earnings Diluted Growth Ratio | -0.136 | 0.329 | 0.000 | 4.073 | 0.000 | |
| Price To Book Ratio | 1.399 | 6.085 | 6.812 | 107.742 | 5.681 | |
| Price To Sales Ratio | 3.135 | 6.860 | 6.146 | 105.372 | 10.287 | |
| Price To Free Cash Flow Ratio | -8.379 | -20.740 | -13.437 | -166.766 | -13.367 | |
| Price To Operating Cash Flow Ratio | -11.547 | -24.351 | -14.943 | -181.345 | -15.139 | |
| Debt To Assets Ratio | 0.004 | 0.009 | 0.014 | 0.000 | 0.000 | |
| Debt To Equity Ratio | 0.004 | 0.011 | 0.017 | 0.000 | 0.000 | |
| Debt To Capital Ratio | 0.004 | 0.011 | 0.017 | 0.000 | 0.000 | |
| Long Term Debt To Capital Ratio | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Financial Leverage Ratio | 1.137 | 1.216 | 1.225 | 1.181 | 1.080 | |
| Working Capital Turnover Ratio | 0.644 | 1.187 | 0.000 | 1.054 | 0.000 | |
| Operating Cash Flow Ratio | -1.027 | -1.821 | -2.087 | -3.573 | -5.696 | |
| Operating Cash Flow Sales Ratio | -0.272 | -0.282 | -0.411 | -0.581 | -0.680 | |
| Free Cash Flow Operating Cash Flow Ratio | 1.378 | 1.174 | 1.112 | 1.087 | 1.133 | |
| Debt Service Coverage Ratio | -73.115 | 0.000 | 0.000 | 0.000 | -4.003 | |
| Interest Coverage Ratio | 0.000 | 0.000 | 0.000 | 0.000 | -4.419 | |
| Short Term Operating Cash Flow Coverage Ratio | -49.225 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Operating Cash Flow Coverage Ratio | -29.041 | -22.182 | -26.352 | 0.000 | 0.000 | |
| Capital Expenditure Coverage Ratio | -2.645 | -5.743 | -8.924 | -11.439 | -7.543 | |
| Dividend Paid And Capex Coverage Ratio | -2.645 | -5.743 | -8.924 | -11.439 | -7.543 | |
| Dividend Payout Ratio | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Enterprise Value Multiple | -3.005 | -13.831 | -8.841 | -437.621 | -25.114 |
Sparkline shows each ratio oldest → newest (left → right).
How the latest year compares
For each ratio: its most recent value, the change versus one year earlier, and versus its 5-year average. ▲ higher ▼ lower
| Metric | Current | vs 1Y ago | vs 5Y avg |
|---|---|---|---|
| Gross Profit Margin | 35.4% | ▲3.5% | ▲0.8% |
| Ebit Margin | -50.2% | ▲1.9% | ▼-1.1% |
| Ebitda Margin | -40.3% | ▲3.6% | ▲1.5% |
| Operating Profit Margin | -56.7% | ▼-3.4% | ▼-5.6% |
| Pretax Profit Margin | -50.2% | ▲1.9% | ▲1.0% |
| Continuous Operations Profit Margin | -50.3% | ▲1.9% | ▲1.0% |
| Net Profit Margin | -50.3% | ▲1.9% | ▲1.0% |
| Bottom Line Profit Margin | -50.3% | ▲5.4% | ▲2.3% |
| Current Ratio | 8.725 | ▲1.165 | ▲0.026 |
| Quick Ratio | 7.841 | ▲1.558 | ▲0.607 |
| Solvency Ratio | -1.316 | ▲0.487 | ▲0.862 |
| Cash Ratio | 7.314 | ▲2.132 | ▲1.902 |
| Price To Earnings Ratio | -6.236 | ▲6.074 | ▲80.240 |
| Price To Earnings Growth Ratio | -0.136 | ▼-0.465 | ▼-0.989 |
| Forward Price To Earnings Growth Ratio | -0.136 | ▼-0.465 | ▼-0.989 |
| Price To Earnings Diluted Ratio | -6.236 | ▲6.074 | ▲80.240 |
| Price To Earnings Diluted Growth Ratio | -0.136 | ▼-0.465 | ▼-0.989 |
| Price To Book Ratio | 1.399 | ▼-4.686 | ▼-24.145 |
| Price To Sales Ratio | 3.135 | ▼-3.724 | ▼-23.225 |
| Price To Free Cash Flow Ratio | -8.379 | ▲12.361 | ▲36.158 |
| Price To Operating Cash Flow Ratio | -11.547 | ▲12.805 | ▲37.918 |
| Debt To Assets Ratio | 0.004 | ▼-0.006 | ▼-0.002 |
| Debt To Equity Ratio | 0.004 | ▼-0.007 | ▼-0.002 |
| Debt To Capital Ratio | 0.004 | ▼-0.007 | ▼-0.002 |
| Long Term Debt To Capital Ratio | 0.000 | 0.000 | 0.000 |
| Financial Leverage Ratio | 1.137 | ▼-0.079 | ▼-0.031 |
| Working Capital Turnover Ratio | 0.644 | ▼-0.544 | ▲0.067 |
| Operating Cash Flow Ratio | -1.027 | ▲0.794 | ▲1.814 |
| Operating Cash Flow Sales Ratio | -0.272 | ▲0.010 | ▲0.173 |
| Free Cash Flow Operating Cash Flow Ratio | 1.378 | ▲0.204 | ▲0.201 |
| Debt Service Coverage Ratio | -73.115 | ▼-73.115 | ▼-57.691 |
| Interest Coverage Ratio | 0.000 | 0.000 | ▲0.884 |
| Short Term Operating Cash Flow Coverage Ratio | -49.225 | ▼-49.225 | ▼-39.380 |
| Operating Cash Flow Coverage Ratio | -29.041 | ▼-6.859 | ▼-13.526 |
| Capital Expenditure Coverage Ratio | -2.645 | ▲3.098 | ▲4.613 |
| Dividend Paid And Capex Coverage Ratio | -2.645 | ▲3.098 | ▲4.613 |
| Dividend Payout Ratio | 0.000 | 0.000 | 0.000 |
| Enterprise Value Multiple | -3.005 | ▲10.827 | ▲94.678 |
Key metrics
| Metric | Trend | 2025 | 2024 | 2023 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Market cap | $227.4M | $521.8M | $402.8M | $9.59B | $524.4M | |
| Enterprise value | $87.8M | $461.8M | $376.5M | $9.56B | $459.3M | |
| EV / Sales | 1.21x | 6.07x | 5.75x | 105.09x | 9.01x | |
| EV / Op. cash flow | -4.46x | -21.55x | -13.97x | -180.85x | -13.26x | |
| EV / Free cash flow | -3.23x | -18.36x | -12.56x | -166.31x | -11.71x | |
| EV / EBITDA | -3.00x | -13.83x | -8.84x | -437.62x | -25.11x | |
| Net debt / EBITDA | 4.78x | 1.80x | 0.62x | 1.19x | 3.56x | |
| Current ratio | 8.72x | 7.56x | 4.94x | 6.68x | 15.59x | |
| Income quality | 0.54x | 0.54x | 0.54x | 2.09x | 1.37x | |
| Graham net-net | $17 | $4 | $3 | $0 | $5 | |
| Tax burden | 100.1% | 100.1% | 100.1% | 100.1% | 100.1% | |
| Interest burden | 100.0% | 100.0% | 100.0% | 103.5% | 124.6% | |
| Working capital | $148.1M | $77.2M | $50.9M | $84.0M | $88.7M | |
| Invested capital | $164.5M | $92.5M | $59.5M | $90.2M | $93.5M | |
| Return on assets | -19.7% | -38.0% | -69.5% | -24.1% | -25.3% | |
| Operating ROA | -28.5% | -46.0% | 0.0% | -24.5% | 0.0% | |
| Return on tangible assets | -21.1% | -42.9% | -75.3% | -24.3% | -25.7% | |
| Return on equity | -22.4% | -46.3% | -85.1% | -28.5% | -27.3% | |
| Return on invested capital | -24.8% | -43.6% | -85.1% | -27.8% | -21.6% | |
| Return on capital employed | -24.9% | -43.9% | -86.2% | -27.8% | -21.6% | |
| Earnings yield | -16.0% | -7.6% | -12.5% | -0.3% | -4.8% | |
| Free cash flow yield | -11.9% | -4.8% | -7.4% | -0.6% | -7.5% | |
| Capex / Op. cash flow | -37.8% | -17.4% | -11.2% | -8.7% | -13.3% | |
| Capex / Depreciation | 103.2% | 59.7% | 39.2% | 177.1% | 238.5% | |
| Capex / Sales | 10.3% | 4.9% | 4.6% | 5.1% | 9.0% | |
| SG&A / Sales | 45.7% | 36.5% | 40.8% | 21.0% | 27.5% | |
| R&D / Sales | 46.5% | 48.9% | 67.2% | 39.7% | 54.5% | |
| Stock comp / Sales | 9.4% | 6.8% | 4.0% | 1.4% | 1.4% | |
| Intangibles / Total assets | 6.3% | 11.2% | 7.7% | 0.7% | 1.6% | |
| Days sales outstanding | 37d | 50d | 68d | 83d | 79d | |
| Days payables outstanding | 67d | 21d | 19d | 67d | 35d | |
| Operating cycle | 169d | 156d | 238d | 287d | 171d | |
| Cash conversion cycle | 102d | 135d | 219d | 220d | 136d |
Change by theme
Grouped by what each metric measures. Each figure is the change over the period shown — ▲ up ▼ down versus then.
Change over 1 year
Valuation
Market cap ▼-56.4%EV / Sales ▼-80.1%EV / EBITDA ▲+78.3%EV / Op. cash flow ▲+17.094Earnings yield ▼-0.084
Profitability
Return on equity ▲+0.238Return on assets ▲+0.183Return on invested capital ▲+0.188Return on capital employed ▲+0.190Operating ROA ▲+0.175Income quality -0.000Tax burden +0.000
Efficiency
Days sales outstanding ▼-13.234Days payables outstanding ▲+46.190Operating cycle ▲+13.006Cash conversion cycle ▼-33.184Capex / Sales ▲+0.054R&D / Sales ▼-0.024
Balance-sheet strength
Current ratio ▲+1.165Net debt / EBITDA ▲+2.982Working capital ▲+70953000.000Invested capital ▲+72048000.000Intangibles / Total assets ▼-0.050
Change over 5 years
Valuation
Market cap ▼-56.6%EV / Sales ▼-86.6%EV / EBITDA ▲+88.0%EV / Op. cash flow ▲+8.804Earnings yield ▼-0.112
Profitability
Return on equity ▲+0.049Return on assets ▲+0.056Return on invested capital ▼-0.032Return on capital employed ▼-0.033Operating ROA n/aIncome quality ▼-0.833Tax burden +0.000
Efficiency
Days sales outstanding ▼-42.056Days payables outstanding ▲+31.918Operating cycle ▼-2.320Cash conversion cycle ▼-34.238Capex / Sales ▲+0.013R&D / Sales ▼-0.081
Balance-sheet strength
Current ratio ▼-6.863Net debt / EBITDA ▲+1.223Working capital ▲+59436000.000Invested capital ▲+70988000.000Intangibles / Total assets ▲+0.047
Employee count
Peer market caps
Congressional trades
No congressional trade data synced.
Recent news
- 2026-08-27 Does Ambiq Micro, Inc. (AMBQ) Have the Potential to Rally 40.96% as Wall Street Analysts Expect? The average of price targets set by Wall Street analysts indicates a potential upside of 41% in Ambiq Micro, Inc. (AMBQ). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
- 2026-08-12 Ambiq''s Q2 Earnings Surpass Estimates, Revenues Rise Y/Y AMBQ''s Q2 earnings beat estimates as Edge AI demand drives an 89.7% revenue surge, while margins expand and growth stays strong.
- 2026-08-12 Ambiq Micro Analysts Increase Their Forecasts After Strong Q2 Results Ambiq Micro Inc (NASDAQ:AMBQ) on Tuesday reported better-than-expected second-quarter financial results and issued strong third-quarter guidance.
- 2026-08-11 Ambiq Micro, Inc. (AMBQ) Q2 2026 Earnings Call Transcript Ambiq Micro, Inc. (AMBQ) Q2 2026 Earnings Call Transcript
- 2026-08-11 Ambiq Micro Q2 Earnings Call Highlights Ambiq Micro NYSE: AMBQ reported second-quarter 2026 net sales of $33.9 million, up 89.7% from a year earlier, as demand for edge artificial intelligence applications accelerated across its customer base and product portfolio.
- 2026-08-11 Ambiq Micro, Inc. (AMBQ) Reports Q2 Loss, Tops Revenue Estimates Ambiq Micro, Inc. (AMBQ) came out with a quarterly loss of $0.07 per share versus the Zacks Consensus Estimate of a loss of $0.26. This compares to a loss of $0.43 per share a year ago.
- 2026-08-11 Ambiq Reports Second Quarter 2026 Financial Results Ambiq Micro, Inc. (âAmbiqâ) (NYSE: AMBQ), a technology leader in ultra-low-power semiconductor solutions for edge AI, today announced financial results for
- 2026-08-11 Ambiq Reports Second Quarter 2026 Financial Results AUSTIN, Texas--(BUSINESS WIRE)---- $AMBQ #AI--Ambiq Reports Second Quarter 2026 Financial Results.
- 2026-08-07 Wasatch Micro Cap Fund Q2 2026 Contributors And Detractors The leading contributor was Ambiq Micro, Inc. (AMBQ) , a designer of ultra-low power semiconductor solutions that went public in July of 2025. Suncrete''s stock moved higher in the wake of strong first quarter revenue growth. TriSalus posted a significant miss on revenues and lowered guidance during the quarter, citing the impact of a Salesforce (CRM) reorganization and delayed FDA review of its next-generation device.
- 2026-08-04 Ambiq Micro, Inc. (AMBQ) May Report Negative Earnings: Know the Trend Ahead of Next Week''s Release Ambiq Micro, Inc. (AMBQ) doesn''t possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.